{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:58:32Z","timestamp":1791406712237,"version":"4.3.3"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["13120052"],"award-info":[{"award-number":["13120052"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Area of Excellence Scheme","award":["AoE\/M-12\/06"],"award-info":[{"award-number":["AoE\/M-12\/06"]}]},{"name":"Theme-based grant","award":["T11-705\/14N"],"award-info":[{"award-number":["T11-705\/14N"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.antiviral.2017.06.009","type":"journal-article","created":{"date-parts":[[2017,6,17]],"date-time":"2017-06-17T02:01:22Z","timestamp":1497664882000},"page":"186-195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Identification of influenza polymerase inhibitors targeting polymerase PB2 cap-binding domain through virtual screening"],"prefix":"10.1016","volume":"144","author":[{"given":"Ming","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yeung","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7621-0851","authenticated-orcid":false,"given":"Hak-Fun","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6004-7041","authenticated-orcid":false,"given":"Jacky Chi-Ki","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Chi-Cheong","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo Lit-Man","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pang-Chui","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2017.06.009_bib1","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/AAC.49.2.556-559.2005","article-title":"Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations","volume":"49","author":"Abed","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2017.06.009_bib2","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1128\/AAC.04623-14","article-title":"Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit","volume":"59","author":"Byrn","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2017.06.009_bib3","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1021\/jm5007275","article-title":"Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2","volume":"57","author":"Clark","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2017.06.009_bib4","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jama.2009.294","article-title":"Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States","volume":"301","author":"Dharan","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2017.06.009_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6","article-title":"Automated docking of flexible ligands: applications of AutoDock","volume":"9","author":"Goodsell","year":"1996","journal-title":"J.\u00a0Mol. Recognit."},{"key":"10.1016\/j.antiviral.2017.06.009_bib6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nsmb.1421","article-title":"The structural basis for cap binding by influenza virus polymerase subunit PB2","volume":"15","author":"Guilligay","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2017.06.009_bib7","doi-asserted-by":"crossref","first-page":"24980","DOI":"10.1074\/jbc.M114.559708","article-title":"A\u00a0novel functional site in the PB2 subunit of influenza A virus essential for acetyl-CoA interaction, RNA polymerase activity, and viral replication","volume":"289","author":"Hatakeyama","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2017.06.009_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/infdis\/jiq012","article-title":"Emerging influenza antiviral resistance threats","volume":"203","author":"Hayden","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.06.009_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1472-6807-6-19","article-title":"LIGSITE(csc): predicting ligand binding sites using the Connolly surface and degree of conservation","volume":"6","author":"Huang","year":"2006","journal-title":"Bmc. Struct. Biol."},{"key":"10.1016\/j.antiviral.2017.06.009_bib10","doi-asserted-by":"crossref","first-page":"e5658","DOI":"10.1371\/journal.pone.0005658","article-title":"Full factorial analysis of mammalian and avian influenza polymerase subunits suggests a role of an efficient polymerase for virus adaptation","volume":"4","author":"Li","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2017.06.009_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.antiviral.2017.06.009_bib12","doi-asserted-by":"crossref","first-page":"11013","DOI":"10.1074\/jbc.M112.392878","article-title":"Structural and functional characterization of K339T substitution identified in the PB2 subunit cap-binding pocket of influenza A virus","volume":"288","author":"Liu","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2017.06.009_bib13","first-page":"131","article-title":"Identification of lead inhibitors targeting influenza A virus nucleoprotein through surface plasmon resonance screening","volume":"3","author":"Lo","year":"2015","journal-title":"Biodesign"},{"issue":"19","key":"10.1016\/j.antiviral.2017.06.009_bib14","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1007\/s00018-014-1615-2","article-title":"Antiviral strategies against influenza virus: towards new therapeutic approaches","volume":"71","author":"Loregian","year":"2014","journal-title":"Cell Mol. Life Sci."},{"issue":"21","key":"10.1016\/j.antiviral.2017.06.009_bib15","doi-asserted-by":"crossref","first-page":"8915","DOI":"10.1021\/jm401369y","article-title":"New 7-methylguanine derivatives targeting the influenza polymerase PB2 cap-binding domain","volume":"56","author":"Pautus","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2017.06.009_bib16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/1087057109332595","article-title":"Fragment-based screening using surface plasmon resonance technology","volume":"14","author":"Perspicace","year":"2009","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.antiviral.2017.06.009_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0065-2571(85)90068-8","article-title":"The importance of IMP dehydrogenase inhibition in the broad spectrum antiviral activity of ribavirin and selenazofurin","volume":"24","author":"Robins","year":"1985","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.antiviral.2017.06.009_bib18","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1021\/jm100574m","article-title":"Understanding and Predicting Druggability. A high-throughput method for detection of drug bindingsites","volume":"53","author":"Schmidtke","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2017.06.009_bib19","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1126\/science.177.4050.705","article-title":"Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide","volume":"177","author":"Sidwell","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2017.06.009_bib20","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1021\/ci100241y","article-title":"Analyzing the topology of active sites: on the prediction of pockets and subpockets","volume":"50","author":"Volkamer","year":"2010","journal-title":"J.\u00a0Chem. Inf. Model"},{"key":"10.1016\/j.antiviral.2017.06.009_bib21","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1021\/ci200454v","article-title":"Combining global and local measures for structure-based druggability predictions","volume":"52","author":"Volkamer","year":"2012","journal-title":"J.\u00a0Chem. Inf. Model"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216305848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216305848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T16:50:52Z","timestamp":1535734252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216305848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":21,"alternative-id":["S0166354216305848"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.06.009","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of influenza polymerase inhibitors targeting polymerase PB2 cap-binding domain through virtual screening","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}